"Misoprostol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A synthetic analog of natural prostaglandin E1. It produces a dose-related inhibition of gastric acid and pepsin secretion, and enhances mucosal resistance to injury. It is an effective anti-ulcer agent and also has oxytocic properties.
| Descriptor ID |
D016595
|
| MeSH Number(s) |
D10.251.355.255.550.775.450.500 D23.469.050.175.725.775.450.500 D23.469.700.660.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Misoprostol".
Below are MeSH descriptors whose meaning is more specific than "Misoprostol".
This graph shows the total number of publications written about "Misoprostol" by people in this website by year, and whether "Misoprostol" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1996 | 0 | 1 | 1 |
| 1999 | 0 | 1 | 1 |
| 2001 | 0 | 1 | 1 |
| 2002 | 1 | 1 | 2 |
| 2004 | 0 | 1 | 1 |
| 2008 | 0 | 2 | 2 |
| 2009 | 1 | 2 | 3 |
| 2010 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
| 2020 | 0 | 1 | 1 |
| 2021 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
| 2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Misoprostol" by people in Profiles.
-
Medication abortion with misoprostol-only: A sample protocol. Contraception. 2023 05; 121:109998.
-
Experiences of Using Misoprostol in the Management of Incomplete Abortions: A Voice of Healthcare Workers in Central Malawi. Int J Environ Res Public Health. 2022 Sep 23; 19(19).
-
Misoprostol treatment prevents hypoxia-induced cardiac dysfunction through a 14-3-3 and PKA regulatory motif on Bnip3. Cell Death Dis. 2021 11 26; 12(12):1105.
-
Medication abortion use among low-income and rural Texans before and during state-imposed restrictions and after FDA-updated labeling. Am J Obstet Gynecol. 2020 08; 223(2):236.e1-236.e8.
-
A comparison of cervical ripening modalities among overweight and obese nulliparous gravidas. J Matern Fetal Neonatal Med. 2020 Nov; 33(22):3804-3808.
-
Standardizing Second-Trimester Medical Termination: Effects on Clinical Outcomes. Am J Perinatol. 2018 07; 35(8):791-795.
-
Lack of evidence for neonatal misoprostol neurodevelopmental toxicity in C57BL6/J mice. PLoS One. 2012; 7(6):e38911.
-
Computerized physician order entry reduces medication turnaround time of labor induction agents. Am J Perinatol. 2011 Apr; 28(4):253-8.
-
Post-partum haemorrhage: beyond the confrontation between misoprostol and oxytocin. Lancet. 2010 Jan 16; 375(9710):176-8.
-
Estimation of potential effects of improved community-based drug provision, to augment health-facility strengthening, on maternal mortality due to post-partum haemorrhage and sepsis in sub-Saharan Africa: an equity-effectiveness model. Lancet. 2009 Oct 24; 374(9699):1441-8.